Antibiotic susceptibility profile of group B streptococcus (Streptococcus agalactiae) at the Maternity Hospital, Kuwait

Medical Principles and Practice

Volumn 14, Issue 4, 2005, Pages 260-263

  Al Sweih, N ^a,b   Jamal, M ^b   Kurdia, M ^b   Abduljabar, R ^b   Rotimi, V ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b AL SABAH HOSPITAL   (Kuwait)

Author keywords

Group B streptococcus; Intrapartum chemoprophylaxis; Susceptibility

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFALOTIN; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN G;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHEMOPROPHYLAXIS; DIFFUSION; KUWAIT; MATERNITY WARD; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREGNANCY; PROPHYLAXIS; SENSITIVITY ANALYSIS; STREPTOCOCCUS AGALACTIAE; TIME SERIES ANALYSIS; VAGINA DISCHARGE;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; DISEASE TRANSMISSION, VERTICAL; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITALS, MATERNITY; HUMANS; INFANT, NEWBORN; KUWAIT; MICROBIAL SENSITIVITY TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; VAGINAL SMEARS;

EID: 20844451451     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085746     Document Type: Article

References (23)

1. Baker CJ: Group B streptococcal infections. Infect Perinatol 1997;24:59-70.
2. Zangwill KM, Schuchat A, Wenger JD: Group B streptococcal disease in the United States, 1990: Report from a multistate active surveillance system. MMWR Morb Mortal Wkly Rep 1992;41:25-32.
3. American College of Obstetricians and Gynecologists: Group B Streptococcal Infections in Pregnancy. Washington, ACOG, 1992. ACOG Techn Bull No 170.
4. Garland SM, Fliegner JR: Group B streptococcus and neonatal infections: The case for intrapartum chemoprophylaxis. Aust NZJ Obstet Gynaecol 1991;31:119-122.
5. Levine EM, Ghai V, Barton JJ, Storm CM: Intrapartum antibiotic prophylaxis increases the incidence of gram-negative neonatal sepsis. Infect Dis Obstet Gynecol 1986;7:210-213.
6. Yow MD, Mason EO, Leeds LJ, Thompson PK, Clark DJ, Gander SE: Ampicillin prevents intrapartum transmission of group B streptococcus. JAMA 1979;241:1245-1247.
7. Lim DV, Morales WJ, Walsh AF, Kazanis D: Reduction of morbidity and mortality rates of neonatal group B streptococcal disease through early diagnosis and chemoprophylaxis. J Clin Microbiol 1986;23:489-492.
8. Boyer KM, Gotoff SP: Prevention of early-on-set neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:1665-1669.
9. Center for Disease Control: Prevention of perinatal group B streptococcus disease: A public health perspective. MMWR Morb Mortal Wkly Rep 1996;45(RR-7):1-24.
10. Berkowitz K, Regan JA, Greenberge E: Antibiotic resistance patterns of group B streptococci in pregnant women. J Clin Microbiol 1990;28:5-7.
11. Betriu C, Gomez M, Sanchez A, Cruceyra A, Romero J, Picazo J: Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci. Antimicrob Agents Chemother 1994;38:2183-2186.
12. Arora A, Jindal N, Walia G, Guati VL: Presumptive identification and antibiotic susceptibility of group B streptococci. Indian J Pathol Microbiol 1994;38:185-190.
13. National Committee for Clinical Laboratory Standards: Performance Standards for Antimicrobial Susceptibility Testing: Eighth Informational Supplement, vol 18, No 1. Wayne, National Committee for Clinical Laboratory Standards, 1998.
14. American College of Obstetricians and Gynecologists: Prevention of early-onset group B streptococcal disease in newborns. ACOG Committee Opinion No 173. Washington, American College of Obstetricians and Gynecologists, 1996.
15. Neu H: Clinical pharmacokinetics in pregnancy and perinatology. II. Penicillins. Dev Pharmacol Ther 1987;10:174-198.
16. Was Z, Hockerl O, Nummi S, Vuopala S, Jarvinen PA: Transplacental passage of azidocillin, ampicillin and penicillin G during early and late pregnancy. Scand J Infect Dis 1970;2:125-130.
17. Baker CJ, Webb BJ, Barrett FF: Antimicrobial susceptibility of group B streptococci isolated from a variety of clinical sources. Antimicrob Agents Chemother 1976;10:128-131.
18. Tsakris A, Maniatis AN: Inducible type of erythromycin resistance among group B streptococci isolated in Greece. J Antimicrob Chemother 1993;31:177-178.
19. Fernandez M, Hickman ME, Baker CJ: Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother 1998;42:1517-1519.
20. Pearlman MD, Pierson CL, Faix RG: Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstet Gynecol 1998;92:256-261.
21. Philipson A, Sabath LD, Charles D: Transplacental passage of erythromycin and clindamycin. N Engl J Med 1973;288:1219-1221.
22. Committee on Infectious Diseases: 1997 Red Book: Report of the Committee on Infectious Diseases, ed 24. Elk Grove Village, American Academy of Pediatrics, 1997, pp 504-514.
23. Petz LD: Immunologic cross-reactivity between penicillin and cephalosporins: A review. J Infect Dis 1978;137:S74-S79.